Skip to main content
Premium Trial:

Request an Annual Quote

CRUK's Commercial Branch, Abcodia Launch Cancer Biomarker Collaboration

NEW YORK (GenomeWeb News) – Cancer Research UK's commercial arm, Cancer Research Technology (CRT), will partner with the biomarker validation firm Abcodia to develop blood tests for detecting early-stage cancers, CRUK said today.

The collaborators will harness Abcodia's longitudinal biomarker profiling expertise and CRUK's scientific network. They will have access to more than five million serum samples contained in the UK Collaborative Trial for Ovarian Cancer Screening at University College London. That trial, which has taken samples from people who were healthy for as long as 10 years before some of them were diagnosed with cancer, is funded in part by CRUK.

CRT and UK-based Abcodia plan to use this sample collection to select biomarkers that provide clear indicators for changes in the early stages of disease.

They will focus their attention on markers that may be expressed in serum, such as proteins, microRNAs, DNA methylation, cell derived vesicles, and autoantibody markers, and they will investigate both genetic and acquired risk factors.

The collaborators also plan to jointly commercialize any biomarkers they discover and to share the resulting revenues with any third-party partners through license arrangements.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.